Prof. Dr. J. (Jolanda) Kluin

Clinical Decision Making

• 2024: How microsimulation translates outcome estimates to patient lifetime event occurrence in the setting of heart valve disease.

  Notenboom, M. L., Rhellab, R., Etnel, J. R. G., Huygens, S. A., Hjortnaes, J., Kluin, J., Takkenberg, J. J. M., & Veen, K. M.
  In: European journal of cardio-thoracic surgery 2024;65(3): ezae087.

• 2024: The future of valvular heart disease assessment and therapy. Sengupta, P. P., Kluin, J., Lee, S. P., Oh, J. K., & Smits, A. I. P. M. 
  In:  Lancet 2024;403(10436):1590–1602.
• 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.

  Collet JP, Thiele H, Barbato E, Barthélémy O, Bauersachs J, Bhatt DL, Dendale P, Dorobantu M, Edvardsen T, Folliguet T, Gale CP, Gilard M, Jobs A, Jüni P, Lambrinou E, Lewis BS, Mehilli J, Meliga E, Merkely B, Mueller C, Roffi M, Rutten FH, Sibbing D, Siontis GCM; ESC Scientific Document Group (Review Committee).
  In: European Heart Journal 2021;42:1289-1367.

• 2020: ESC Guidelines for the management of adult congenital heart disease.

  Baumgartner H, De Backer J, Babu-Narayan SV, Budts W, Chessa M, Diller GP, Lung B, Kluin J, Lang IM, Meijboom F, Moons P, Mulder BJM, Oechslin E, Roos-Hesselink JW, Schwerzmann M, Sondergaard L, Zeppenfeld K; ESC Scientific Document Group.
  In: European Heart Journal 2021;42:563-645.

• 2018: ESC Guidelines for the management of cardiovascular diseases during pregnancy.

  Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomström-Lundqvist C, Cífková R, De Bonis M, Iung B, Johnson MR, Kintscher U, Kranke P, Lang IM, Morais J, Pieper PG, Presbitero P, Price S, Rosano GMC, Seeland U, Simoncini T, Swan L, Warnes CA; ESC Scientific Document Group (Review Committee).
  In: European Heart Journal 2018;39:3165-3241.

• 2017: Does the use of a decision aid improve decision making in prosthetic heart valve selection? A multicenter randomized trial.

  Korteland NM, Ahmed Y, Koolbergen DR, Brouwer M, de Heer F, Kluin J, Bruggemans EF, Klautz RJ, Stiggelbout AM, Bucx JJ, Roos-Hesselink JW, Polak P, Markou T, van den Broek I, Ligthart R, Bogers AJ, Takkenberg JJ.
  In: Circulation Cardiovascular Quality Outcomes 2017;10: e003178.

  Imaging

• 2024: Virtual Reality for Pain and Anxiety Management in Cardiac Surgery and Interventional Cardiology.

  El Mathari, S., Hoekman, A., Kharbanda, R. K., Sadeghi, A. H., de Lind van Wijngaarden, R., Götte, M., Klautz, R. J. M., & Kluin, J.
  In: Management in Cardiac Surgery and Interventional Cardiology 2024;3(2): 100814.

• 2018: Advanced cardiac MRI techniques for evaluation of left-sided valvular heart disease.

  Blanken CPS, Farag ES, Boekholdt SM, Leiner T, Kluin J, Nederveen AJ, van Ooij P, Planken RN.
  In: Journal of Magnetic Resonance Imaging 2018;48:318-329.

• 2013: Automated 3D analysis of pre-procedural MDCT to predict annulus plane angulation and C- arm positioning: benefit on procedural outcome in patients referred for TAVR.

  Samim M, Stella PR, Agostoni P, Kluin J, Ramjankhan F, Budde RP, Sieswerda G, Algeri E, van Belle C, Elkalioubie A, Juthier F, Belkacemi A, Bertrand ME, Doevendans PA, van Belle E.
  In: Journal of the American College of Cardiology Cardiovascular Imaging 2013;6:238-248.

• 2006: Preoperative computed tomography coronary angiography to detect significant coronary artery stenosis in patients referred for valve surgery.

  Meijboom WB, Mollet NR, van Mieghem CAG, Kluin J, Weustink AC, Pugliese F, Vourvouri E, Cademartiri F, Bogers AJ, Krestin GP, de Feyter P.
  In: Journal of the American College of Cardiology 2006;48:1658-1665.

  Translational (development new heart valves, tissue engineering)

• 2023: Valvulogenesis of a living, innervated pulmonary root induced by an acellular scaffold.

  Yacoub MH, Tseng YT, Kluin J, Vis A, Stock U, Smail H, Sarathchandra P, Aikawa E, El-Nashar H, Chester AH, Shehata N, Nagy M, El-Sawy A, Li W, Burriesci G, Salmonsmith J, Romeih S, Latif N.
  In: Commun Biol. 2023 Oct 7;6(1):1017.

• 2020: In situ remodeling overrules bioinspired scaffold architecture of supramolecular elastomeric tissue-engineered heart valves.

  Uiterwijk M, Smits AIPM, van Geemen D, van Klarenbosch B, Dekker S, Cramer MJ, van Rijswijk JW, Lurier EB, Di Luca A, Brugmans MCP, Mes T, Bosman AW, Aikawa E, Gründeman PF, Bouten CVC, Kluin J.
  In: Journal of the American College of Cardiology Basic to Translational Science 2020;5:1187-1206.

• 2017: In situ tissue engineering using a bioresorbable elastomeric implant – from material design to 12 months follow-up in sheep.

  Kluin J, Talacua H, Smits AI, Emmert MY, Brugmans MC, Fioretta ES, Dijkman PE, Sontjens SH, Duijvelshof R, Dekker S, Janssen-van den Broek MW, Lintas V, Hoerstrup SP, Janssen HM, Dankers PY, Baaijens FP, Bouten CV.
  In: Biomaterials 2017;125:101-107.

• 2016: Early in situ cellularization of a supramolecular vascular graft is modified by synthetic stromal cell derived factor 1α derived peptides.

  Muylaert DEP, van Almen GC, Talacua H, Fledderus JO, Kluin J, Hendrikse SIS, van Dongen JLJ, Sijbesma E, Bosman AW, Mes T, Thakkar SH, Smits AIPM, Bouten CVC, Dankers PYW, Verhaar MC.
  In: Biomaterials 2016;76:187-195.

• 2015: In situ tissue engineering of functional small-diameter blood vessels by host circulating cells only.
  Talacua H, Smits AI, Muylaert DE, van Rijswijk JW, Vink A, Verhaar MC, Driessen-Mol A, van Herwerden LA, Bouten CV, Kluin J, Baaijens FP.
  In: Tissue Engineering Part A 2015;21:2583-2594